维普中文期刊产品整合服务
82篇 您的检索式:作者名="Lyon RM"
    题名 作者 年代 出处 被引量
1Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomized controlled trial 显示文摘Kuter D J Bussel JB Lyons RM 2008Lancet2008,371,9610:1
2The cell biology of trans forming grow the factor显示文摘Barnard JA Lyons RM Moses HI 1990Biochem Biophys Acta1990,1032,1:1
3Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes 显示文摘Lyons RM Cosgriff TM Modi SS 2009J Clin Oncol2009,27,11:1
4Efficacy of romiplostimin patients with chronic immune thrombocytopenicpurpura:a double- blind randomised controlled trial显示文摘Kuter DJ Bussel JB Lyons RM 2008Lancet2008,371,5:1
5Transforming growth factors and the regulation of cell proliferation显示文摘Russette M Lyons RM Moses HL 1990Eur J Biochem1990,187,:1
6Lateral elbow ecchymosis as a clinical sign of lateral humeral condylar fractures显示文摘Meyer NJ Lyon RM 2003Am J Orthop2003,32,5:1
7Efficacy of romiplostimin patients with chronic immune thrombocytopenicpurpura: a double- blind randomised controlled trial 显示文摘KUTER DJ BUSSEL JB LYONS RM 2008Lancet2008,371,9610:1
8Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial显示文摘KUTER DJ BUSSEL JB LYONS RM 2008Lancet2008,371,9610:1
9Inflammatory cytokine mRNAs in surgical specimeas of necrotizing enterocolitis and normal newborn intestine显示文摘Viscanti RM Lyon NH Sun CC 1997Pediatr Pathol Lab Med1997,17,4:1
10Efficacy ofromiplostim in patients with chronic immune thrombocyto-penic purpura : a double - blind randomised controlled trial显示文摘KUTER DJ BUSSEL JB LYONS RM 2008Lancet2008,371,9610:1
11Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double- blind randomised controlled trial 显示文摘KUTER D J BUSSEL JB LYONS RM 2008Lancet2008,371,9610:1
12A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide 显示文摘Wang ES Lyons RM Larson RA 2012J Hematol Oncol2012,5,:1
13Advances in the hospital management of patients following an out of hospital cardiac arrest显示文摘Nolan JP Lyon RM Sasson C 2012Heart2012,98,:1
14Myelodysplastic syndromes: therapy and outlook显示文摘Lyons RM 2012Am J Med2012,125,7:1
15Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura:a double-blind randomised controlled trial显示文摘Kuter D J Bussel JB Lyons RM 0,,9610:1
16Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy 显示文摘Lyon TD Turner li RM Nikonow TN 2016J Surg Oncol2016,113,2:1
17The cell biology of transforming growth factor beta 显示文摘Barnard JA Lyons RM Moses HL 1990Biochim Biophys Acta1990,1032,1:1
18A randomized, double-blind,placebo-controlled phase 2 study evaluating the efficacy andsafety of romiplostim treatment of patients with low or intermediate-1risk myelodysplastic syndrome receiving lenalidomide 显示文摘Wang ES Lyons RM Larson RA 2012JHematol Oncol2012,5,:1
19The cell biology of transforming growth factor beta显示文摘Barnard JA Lyons RM Moses HL 1990Biochim Biophys Acta1990,1032,:1
20Efficacy of romiplostimin patients with chronic immune :a double-blind random- ised controlled trial显示文摘Kuter DJ Bussel JB Lyons RM 2008Lancet2008,371,5:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费